Margaret M. FitzPatrick

Insider Reports History

Entity
Individual
Location
C/O Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret M. FitzPatrick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 64.5K Jun 19, 2024 Direct
Vistagen Therapeutics, Inc. Director Stock Option (Right to Buy) 14.1K Sep 6, 2024 Direct

Insider Reports Filed by Margaret M. FitzPatrick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN Vistagen Therapeutics, Inc. Sep 6, 2024 1 $0 4 Sep 10, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
VTGN Vistagen Therapeutics, Inc. Mar 4, 2024 1 $0 4 Mar 6, 2024 Director
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ANTX AN2 Therapeutics, Inc. May 5, 2022 1 $0 4 May 9, 2022 Director
ANTX AN2 Therapeutics, Inc. May 5, 2022 0 $0 3 May 9, 2022 Director
VTGN VistaGen Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Director
VTGN VistaGen Therapeutics, Inc. Jul 21, 2021 1 $0 4 Jul 22, 2021 Director
VTGN VistaGen Therapeutics, Inc. Jul 21, 2021 0 $0 3 Jul 22, 2021 Director